T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy.
Böhler
T
T
Debatin
K M
KM
Wintergerst
U
U
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D006801:Humans; D007223:Infant; D008213:Lymphocyte Activation / Q000187:drug effects; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects* / Q000473:pathology; D019014:fas Receptor / Q000494:pharmacology
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019014:fas Receptor